205 related articles for article (PubMed ID: 10024582)
1. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide.
Zhang GH; Mann DM; Tsai CM
Infect Immun; 1999 Mar; 67(3):1353-8. PubMed ID: 10024582
[TBL] [Abstract][Full Text] [Related]
2. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL
Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014
[TBL] [Abstract][Full Text] [Related]
4. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
[TBL] [Abstract][Full Text] [Related]
5. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock.
Dankesreiter S; Hoess A; Schneider-Mergener J; Wagner H; Miethke T
J Immunol; 2000 May; 164(9):4804-11. PubMed ID: 10779788
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells.
Mattsby-Baltzer I; Roseanu A; Motas C; Elverfors J; Engberg I; Hanson LA
Pediatr Res; 1996 Aug; 40(2):257-62. PubMed ID: 8827774
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.
Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D
Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946
[TBL] [Abstract][Full Text] [Related]
8. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets.
Lee WJ; Farmer JL; Hilty M; Kim YB
Infect Immun; 1998 Apr; 66(4):1421-6. PubMed ID: 9529062
[TBL] [Abstract][Full Text] [Related]
9. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin.
Brandenburg K; Jürgens G; Müller M; Fukuoka S; Koch MH
Biol Chem; 2001 Aug; 382(8):1215-25. PubMed ID: 11592403
[TBL] [Abstract][Full Text] [Related]
10. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia.
Kirikae T; Hirata M; Yamasu H; Kirikae F; Tamura H; Kayama F; Nakatsuka K; Yokochi T; Nakano M
Infect Immun; 1998 May; 66(5):1861-8. PubMed ID: 9573062
[TBL] [Abstract][Full Text] [Related]
12. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo.
Ren JD; Gu JS; Gao HF; Xia PY; Xiao GX
Int Immunopharmacol; 2008 Jun; 8(6):775-81. PubMed ID: 18442780
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice.
Kruzel ML; Harari Y; Mailman D; Actor JK; Zimecki M
Clin Exp Immunol; 2002 Oct; 130(1):25-31. PubMed ID: 12296849
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide.
Ghiselli R; Giacometti A; Cirioni O; Circo R; Mocchegiani F; Skerlavaj B; D'Amato G; Scalise G; Zanetti M; Saba V
Shock; 2003 Jun; 19(6):577-81. PubMed ID: 12785015
[TBL] [Abstract][Full Text] [Related]
15. [Study of in vitro endotoxin neutralization effect and antibacterial activity of limulus anti-lipopolysaccharide factor simulated peptide REMP2].
Gao HF; Xiao GX; Xia PY; Ren JD
Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):90-2. PubMed ID: 18785404
[TBL] [Abstract][Full Text] [Related]
16. Suppression of lethal toxicity of endotoxin by biscoclaurine alkaloid cepharanthin.
Maruyama H; Kikuchi S; Kawaguchi K; Hasunuma R; Ono M; Ohbu M; Kumazawa Y
Shock; 2000 Feb; 13(2):160-5. PubMed ID: 10670847
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human lactoferrin has preventive effects on lipopolysaccharide-induced preterm delivery and production of inflammatory cytokines in mice.
Otsuki K; Yakuwa K; Sawada M; Hasegawa A; Sasaki Y; Mitsukawa K; Chiba H; Nagatsuka M; Saito H; Okai T
J Perinat Med; 2005; 33(4):320-3. PubMed ID: 16207117
[TBL] [Abstract][Full Text] [Related]
18. Design of a potent novel endotoxin antagonist.
Uknis ME; Wasiluk KR; Acton RD; Klaerner HG; Dahlberg PS; Ilyina EE; Haseman JR; Gray BH; Mayo KH; Dunn DL
Surgery; 1997 Aug; 122(2):380-5. PubMed ID: 9288144
[TBL] [Abstract][Full Text] [Related]
19. Antiendotoxin activity of cationic peptide antimicrobial agents.
Gough M; Hancock RE; Kelly NM
Infect Immun; 1996 Dec; 64(12):4922-7. PubMed ID: 8945527
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
